Intranasal esketamine in treatment-resistant depression, a dose response study - double blind and open label extension data

Category Primary study
ConferenceNeuropsychopharmacology
Year 2015
This article has no abstract
Epistemonikos ID: 0af74fd4fc82a0eb83ff0e6b87c11f898004709a
First added on: Apr 30, 2026